skip to content

Roche's Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.